Comus Locking Plate systems

K190842 · Jiangsu Trauhui Medical Instrument Co., Ltd. · HRS · Feb 3, 2020 · Orthopedic

Device Facts

Record IDK190842
Device NameComus Locking Plate systems
ApplicantJiangsu Trauhui Medical Instrument Co., Ltd.
Product CodeHRS · Orthopedic
Decision DateFeb 3, 2020
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

Comus Locking Plate systems can be used for adult patients with age above 21 as indicated for fixation of Bone fracture in ulna, radius, humerus, femur and tibia.

Device Story

Comus Locking Plate systems consist of metallic plates and screws used for internal bone fixation. Plates are manufactured from titanium (ASTM F67) and screws from titanium alloy (Ti-6Al-4V ELI, ASTM F136). The device is intended for surgical implantation by orthopedic surgeons to stabilize fractures in long bones (ulna, radius, humerus, femur, tibia). The system provides mechanical support to bone segments during the healing process. The device is provided sterile and is intended for single-patient use. Clinical benefit is derived from the stabilization of fractures, facilitating bone union and patient recovery.

Clinical Evidence

No clinical data provided. Substantial equivalence is supported by bench testing only. Comparative performance testing included static and dynamic four-point bending tests for plates, and torsional, driving torque, and pull-out tests for screws, conducted in accordance with ASTM F382-14 and ASTM F543-17 standards.

Technological Characteristics

Materials: Titanium (ASTM F67) for plates, Titanium alloy Ti-6Al-4V ELI (ASTM F136) for screws. Mechanical fixation via locking plate and screw system. Design features include cortical and cancellous bone application, specific geometric shapes, and hole configurations. Sterilization method not explicitly stated but implied as standard for surgical implants. No software or electronic components.

Indications for Use

Indicated for fixation of bone fractures in the ulna, radius, humerus, femur, and tibia in adult patients aged 21 and older.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. Underneath the square are the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. February 3, 2020 Jiangsu Trauhui Medical Instrument Co., Ltd. % Mike Gu Regulatory Affairs Manager Guangzhou Osmunda Medical Device Consulting Co., Ltd 8-9th Floor, R&D Building, No.26 Qinglan Street Panyu District Guangzhou, Guangdong 510006 China Re: K190842 Trade/Device Name: Comus Locking Plate systems Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: March 28, 2019 Received: April 1, 2019 Dear Mike Gu: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K190842 Device Name Comus Locking Plate systems Indications for Use (Describe) Comus Locking Plate systems can be used for adult patients with age above 21 as indicated for fixation of Bone fracture in ulna, radius, humerus, femur and tibia. | Type of Use (Select one or both, as applicable) | |--------------------------------------------------------------------------------------------------------| | <label><input checked="checked" type="checkbox"/> Residential Use (Part 61, SFD 901, Select D)</label> | | <label><input type="checkbox"/> Com. Theater Use (61, SFD 901, Select C)</label> | X Prescription Use (Part 21 CFR 801 Subpart D) | | Over-The-Counter Use (21 CFR 801 Subpart C) ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # ## 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: ### 1. SUBMITTER Jiangsu Trauhui Medical Instrument Co., Ltd No.2 Longqing Road, Wujin Hi-Tech Industrial Zone, Changzhou, Jiangsu, China Tel: (+86) 519-88769966 Fax: (+86) 519-88738899 | Primary<br>Person: | Contact | Mike Gu<br>Regulatory Affairs Manager<br>Guangzhou Osmunda Medical Device Technical Service Co., Ltd.<br>Tel: (+86)-20-6231 6262<br>Fax: (+86) -20-8633 0253 | | | | | | | | |----------------------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|--|--|--|--|--| | Secondary<br>Person: | Contact | ZhouYu<br>Quality Manager<br>Jiangsu Trauhui Medical Instrument Co., Ltd<br>Tel: (+86) 519-88769966<br>Fax: (+86) 519-88738899 | | | | | | | | | Date prepared | | Feb 03, 2020 | | | | | | | | | 2. DEVICE | | | | | | | | | | | Device Name: | | Comus Locking Plate systems | | | | | | | | | Common/Usual Name: | | Comus Locking Plate systems | | | | | | | | | Regulation number | | 21 CFR 888.3030 and 888.3040 | | | | | | | | | Regulation Name | | Single/multiple component metallic bone fixation<br>appliances and accessories | | | | | | | | | Regulation Class: | | II | | | | | | | | | Product Code: | | HRS, HWC | | | | | | | | | Classification Name | | Single/multiple component metallic bone fixation<br>appliances and accessories | | | | | | | | - 3. PREDICATE DEVICES {4}------------------------------------------------ Primary predicate device: K143002, Changzhou Dingjian Medical Appliance Company, Ltd Reference device: K142943, Canwell Medical Co., Ltd. These predicates have not been subject to a design-related recall. ### DEVICE DESCRIPTION 4. The proposed device Comus Locking Plate systems are a combination of plates and screws, which can be used for adult patients with age above 21 as indicated for fixation of fractures. The plate is made of Titanium, which meet ASTM F67, and the screw is made of titanium allov (Ti-6A-14V ELI) which conforms to ASTM F136, which both are widely used for surgical implants with well-known biocompatibility and mechanical properties. ### INDICATIONS FOR USE 5. Comus Locking Plate systems can be used for adult patients with age above 21 as indicated for fixation of Bone fracture in ulna, radius, humerus, femur and tibia. - 6. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE Comus Locking Plate systems are substantially equivalent to the cleared predicate device (K143002) and the reference device (K142943). Comus Locking Plate systems have same indications for use, patient population, material and sterilization with the predicates. In design specification aspect, the plate of the subject device and the predicates all have the same clinical using bone position: cortical bone and cancellous bone, and they have the same plate geometric shape. The subject plate has a similar but a smaller size dimension range than the predicates. In addition, the subject plates have the similar number of holes in the plate design. The screw of the subject device has the same design structure with the predicates, and has a similar dimension range than the predicates. The subject device has a similar mechanical performance with the predicates. Section 7 shows that the testing comparison results of the subject and predicate device is comparable. ### NON-CLINICAL DATA 7. The following non-clinical data were provided in support of the substantial equivalence determination. {5}------------------------------------------------ ### Performance testing Comparative performance tests were conducted between Comus Locking Plate systems and the predicate device, according to ASTM F382-14 and ASTM F543-17. The specific conducted tests are listed below. - l Static four-point bending test of the plate - 트 Dynamic four-point bending test of the plate - 트 Torsional properties of the screw - 트 Driving torque of the screw - . Pull-out test of the screw The test result shows that the subject device is substantial equivalent with the predicate device. ### Biocompatibility The plate is made of Titanium, which meet ASTM F67, and the screw is made of titanium alloy (Ti-6A-l4V ELI) which conforms to ASTM F136, which both are widely used for surgical implants with well-known good biocompatibility. After conducting risk analysis and validation, the production process does not affect the raw material's biological performance. ### Animal Study The subject of this premarket submission, Comus Locking Plate systems do not require animal studies to support substantial equivalence. ### 8. CLINICAL DATA The subject of this premarket submission, Comus Locking Plate systems did not require clinical studies to support substantial equivalence. ### 9. CONCLUSION The non-clinical data support the safety of the device and the performance testing report demonstrate that the Comus Locking Plate system should perform as intended in the specified use conditions. {6}------------------------------------------------ # TRAUHUI From the comparison analysis and the results of comparative performance testing described, Jiangsu Trauhui Medical Instrument Co., Ltd concludes that the Comus Locking Plate systems are substantial equivalent to the predicate devices.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...